News | Cardiac Diagnostics | September 12, 2016

Researcher Receives NIH Grant to Study Effects of PTSD on Cardiovascular Health

Study will assess whether successful PTSD treatment helps veterans improve unhealthy lifestyle behaviors

September 12, 2016 — A Saint Louis University researcher has received a grant to study the effects of treating post-traumatic stress disorder (PTSD) on cardiovascular and metabolic health. Jeffrey Scherrer, Ph.D., associate professor in Family and Community Medicine, received $2,348,320 from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH).

Following the wars in Iraq and Afghanistan, veterans with PTSD have an approximate two-fold increase in hypertension, dyslipidemia, diabetes and ischemic heart disease, Scherrer said. Controlling for depression, anxiety and cardiac risk, women with five or more PTSD symptoms in a 14-year prospective study were more than three times as likely to develop coronary heart disease compared to a non-PTSD control group.

Many veterans with PTSD exhibit unhealthy lifestyle behaviors, including a lack of physical activity, poor nutrition, smoking, drug use and excessive drinking. Some of these habits may be used to cope with trauma and high levels of stress. Long term, these poor health behaviors may account for the greater risk of cardiovascular and metabolic disease in patients with PTSD.

Scherrer’s study will seek to determine if patients who have been successfully treated for PTSD are more likely to adopt a healthier lifestyle.

“If what our pilot data suggests is true and reductions in PTSD symptoms are associated with improved health behaviors, then physicians and therapists can work during the start of PTSD treatment to encourage patients to engage in changing their health behavior,” Scherrer said. “If symptom reduction isn’t related to healthier life choices, it lends support for aggressive health promotion and screening of patients with PTSD treatment.”

If the research finds that a diagnosis of PTSD remains a risk factor for cardiovascular and metabolic disease despite improved health behaviors and symptom reduction, then lifelong aggressive monitoring of these patients is warranted, Scherrer said.

The study will use Veterans Health Administration (VA) medical record data from patients between the ages of 18 and 70, the majority of whom will have served in the Iraqi and Afghani conflicts.

The study has two components. An independent company will do medical chart abstraction to gain data from VA patients being treated for PTSD in clinics that provide cognitive processing therapy or prolonged exposure therapy.

“Medical records lack precision to fully address the question,” Scherrer said. “This is why detailed data from PTSD treatment encounters will be abstracted, then merged with the larger number of variables contained in the VA’s national patient data.”

In the first year of funding, the researchers will collect the medical record data. Analysis will begin in the second year of the study.

Scherrer notes that combat-related activities are not the only reason veterans may suffer from PTSD.

“Trauma for these veterans is not always related to their military service,” Scherrer said. “We could be looking at cases of life-threatening experiences like automobile accidents or childhood trauma. The results from our study should be generalized to other traumas and PTSD experienced in the civilian population.”

Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) under award number 1 R01 HL125424-01A1.

For more information: www.slu.edu/medicine

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Overlay Init